채용

Programa de Pasantias - Área de Calidad (Planta de Calidad)
ARG - Buenos Aires - Pilar
·
On-site
·
Full-time
·
1mo ago
Job Description:
Somos una compañía biofarmacéutica global con más de 130 años de trayectoria, dedicada a la investigación y desarrollo de soluciones innovadoras en salud humana y salud animal.
El Programa de Pasantías“Estrellas del Futuro” está diseñado para que puedas complementar tu formación académica participando en proyectos desafiantes dentro de nuestras diferentes áreas de negocio. Durante la experiencia tendrás la oportunidad de:
-
Colaborar en proyectos según el área en la que te desempeñes.
-
Adquirir experiencia práctica en contextos profesionales asociados a tu carrera..
-
Contar con el acompañamiento de un tutor, quien te brindará orientación y soporte a lo largo de todo el programa.
Requisitos:
-
Se requiere contar con un mínimo de 3 años de carrera cursada.
-
Ser estudiante de carreras: Biología, Química, Farmacia, Medicina, Informática, Ciencias de Datos, Ciencias de la Computación, Ingeniería, o afines.
-
Nivel de inglés avanzado (excluyente).
Beneficios:
-
Asignación estímulo.
-
Esquema presencial, jornada completa en días alternados, 20 horas semanales en total.
-
Horario: 7:00 a 15:30 o 7:30 a 16:00
-
Servicio de combi de Caba a Pilar.
-
Cobertura médica Osde 210.
-
Comedor en planta.
-
Máquina de snacks.
La planta de Calidad se encuentra en Pilar (GBA Norte).
Fecha de ingreso: Agosto 2026
Animate a innovar, aprender y crecer con nosotros. ¡Te esperamos!
Required Skills:
Analytical Problem Solving, Document Management, Office Applications, Process Improvements, Reporting and Analysis, Workload Prioritization
Preferred Skills:
Current Employees apply HERE:
Current Contingent Workers apply HERE:
Search Firm Representatives Please Read Carefully Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.
Employee Status:
Intern/Co-op (Fixed Term)
Relocation:
No relocation
VISA Sponsorship:
No
Travel Requirements:
No Travel Required:
Flexible Work Arrangements:
Hybrid
Shift:
Not Indicated
Valid Driving License:
No
Hazardous Material(s):
N/A
Job Posting End Date:
04/11/2026
A job posting is effective until 11: 59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고

Freelance- Translators/Linguists, English into Spanish (Latin America)
IQVIA · Buenos Aires, Argentina

CRA2 - Argentina
IQVIA · Buenos Aires, Argentina

Document Specialist Analyst
JPMorgan Chase · Ciudad Autónoma de Buenos Aires, Argentina, AR

Linux Systems Administrator
Allegro Micro · Buenos Aires, Argentina

Administrator (Support & Operations)
HCL Technologies · Buenos Aires, Argentina
Merck 소개

Merck
PublicMultinational pharmaceutical company.
10,001+
직원 수
Rahway
본사 위치
$208B
기업 가치
리뷰
4.3
10개 리뷰
워라밸
4.0
보상
3.5
문화
4.2
커리어
3.8
경영진
4.0
78%
친구에게 추천
장점
Supportive management and colleagues
Good work-life balance and flexibility
Excellent benefits and health plans
단점
High-pressure and demanding work environment
Limited career advancement opportunities
Below-average pay for entry-level positions
연봉 정보
2,504개 데이터
Intern
Intern · Process Analysis Intern
1개 리포트
-
총 연봉
기본급
-
주식
-
보너스
-
면접 경험
6개 면접
난이도
3.0
/ 5
소요 기간
14-28주
합격률
17%
경험
긍정 0%
보통 67%
부정 33%
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Background Check
6
Offer
자주 나오는 질문
Behavioral/STAR
Past Experience
Technical Knowledge
Culture Fit
Case Study
뉴스 & 버즈
Merck Unveils First-in-Human Data for PD-1/VEGF Bispecific MK-2010 - Oncodaily
Oncodaily
News
·
1d ago
Does EU Approval Of ENFLONSIA Reshape The Bull Case For Merck’s Pipeline Story (MRK)? - Yahoo Finance
Yahoo Finance
News
·
2d ago
Better Pharma Dividend Stock: Novartis vs. Merck - The Motley Fool
The Motley Fool
News
·
2d ago
AACR: Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans - Fierce Biotech
Fierce Biotech
News
·
2d ago